Mr. Speaker, our government has worked hard to advance research in MS to improve the health of those living with this horrible condition. Along with MS patients, we hope that the research will contribute to a cure.
Over the past five years we have invested more than $27 million in MS research, and we are supporting the development of an MS monitoring system that will provide patients and health care providers with better understanding of the disease and its treatments.
It is critical that we complete clinical trials for CCSVI to assess the safety and effectiveness of this procedure. The U.S. Food and Drug Administration agreed, and warned health practitioners of the need for approval before using it to treat people with MS.